Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry

被引:66
作者
Brockman, MA
Tanzi, GO
Walker, BD
Allen, TM [1 ]
机构
[1] Massachusetts Gen Hosp, Partners AIDS Res Ctr, Boston, MA 02129 USA
[2] Harvard Univ, Sch Med, Div Aids, Boston, MA 02129 USA
[3] Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02129 USA
关键词
human immunodeficiency virus; fitness; flow cytometry; green fluorescent protein;
D O I
10.1016/j.jviromet.2005.08.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The rate of HIV-1 disease progression correlates strongly with plasma viral load and is likely to be influenced by both host and viral determinants. Though interest in the impact of viral replication capacity during HIV-1 infection has been increasing, especially with respect to drug resistance mutations, its influence on disease course remains poorly understood. This is due in part to significant drawbacks in conventional means of measuring HIV-1 growth in vitro (i.e. expense, inconvenience, and experimental variability). A FACS-based method is described here to measure HIV-1 replication sensitively and a modification of this method can be used to determine viral titer accurately. Importantly, the target cells used are permissive to CXCR4- and CCR5-tropic HIV-1 strains. In pilot experiments, the growth kinetics of laboratory-adapted strains NL4-3 and 11113 were examined carefully. Using this method, differences were observed in growth kinetics between three laboratory strains and seven primary isolates, indicating the potential for a broad range of in vitro replication capacities among individual isolates. In conclusion, this FACS-based method provides a sensitive approach to measure the replication capacity of HIV-1 and may prove useful in studies examining the impact of viral fitness on disease progression. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:134 / 142
页数:9
相关论文
共 37 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection [J].
Alexander, L ;
Weiskopf, E ;
Greenough, TC ;
Gaddis, NC ;
Auerbach, MR ;
Malim, MH ;
O'Brien, SJ ;
Walker, BD ;
Sullivan, JL ;
Desrosiers, RC .
JOURNAL OF VIROLOGY, 2000, 74 (09) :4361-4376
[3]   AN INHIBITOR OF THE PROTEASE BLOCKS MATURATION OF HUMAN AND SIMIAN IMMUNODEFICIENCY VIRUSES AND SPREAD OF INFECTION [J].
ASHORN, P ;
MCQUADE, TJ ;
THAISRIVONGS, S ;
TOMASSELLI, AG ;
TARPLEY, WG ;
MOSS, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) :7472-7476
[4]   Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C [J].
Ball, SC ;
Abraha, A ;
Collins, KR ;
Marozsan, AJ ;
Baird, H ;
Quiñones-Mateu, ME ;
Penn-Nicholson, A ;
Murray, M ;
Richard, N ;
Lobritz, M ;
Zimmerman, PA ;
Kawamura, T ;
Blauvelt, A ;
Arts, EJ .
JOURNAL OF VIROLOGY, 2003, 77 (02) :1021-1038
[5]   Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults [J].
Barbour, JD ;
Wrin, T ;
Grant, RM ;
Martin, JN ;
Segal, MR ;
Petropoulos, CJ ;
Deeks, SG .
JOURNAL OF VIROLOGY, 2002, 76 (21) :11104-11112
[6]   A SINGLE AMINO-ACID SUBSTITUTION IN THE V1 LOOP OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP120 ALTERS CELLULAR TROPISM [J].
BOYD, MT ;
SIMPSON, GR ;
CANN, AJ ;
JOHNSON, MA ;
WEISS, RA .
JOURNAL OF VIROLOGY, 1993, 67 (06) :3649-3652
[7]   Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma [J].
Campbell, TB ;
Schneider, K ;
Wrin, T ;
Petropoulos, CJ ;
Connick, E .
JOURNAL OF VIROLOGY, 2003, 77 (22) :12105-12112
[8]  
Candotti D, 1999, J MED VIROL, V58, P256, DOI 10.1002/(SICI)1096-9071(199907)58:3&lt
[9]  
256::AID-JMV11&gt
[10]  
3.0.CO